#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine carcinoma Hodgkin's disease refractory Pulmonary hypertension Crigler-Najjar syndrome Glycogen storage disease type V Haemophilia B without inhibitors Polycystic liver disease Plasma cell myeloma Waldenstrom's macroglobulinaemia refractory Antiphospholipid syndrome Hairy cell leukaemia recurrent Neurotrophic keratopathy Neonatal alloimmune thrombocytopenia Dedifferentiated liposarcoma Congenital pseudarthrosis More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis Angiosarcoma – Trials in Disease Pulmonary fibrosis – Treatment Mitochondrial myopathy – Treatment Adrenocortical carcinoma Short-bowel syndrome – Basic Information Acute respiratory distress syndrome – Diagnostics Adrenogenital syndrome – Trials in Disease Glycogen storage disease type I – Basic Information Haemophagocytic lymphohistiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mexiletine Cart45Ra-Nkg2D Cells Lisinopril Tecovirimat Oxogluric Acid Tiapride Cimetidine Cd7-Cart01 AGA2118 Acetylcholine Chloride Vosilasarm Entrectinib Tebentafusp BNT327 Sulpiride Eliglustat Tartrate Ertugliflozin Ace Inhibitors, Plain ENSIFENTRINE Nalbuphine Hydrochloride More therapies…

    Learn about Your Condition

    Wolfram syndrome Cluster headache Immune-mediated renal disorder Alcoholism Desmoplastic melanoma Cardiac failure chronic Colon cancer metastatic Metabolic disorder Hepatoblastoma Herpes zoster Tympanic membrane hyperaemia Tourette's disorder Coma Henoch-Schonlein purpura Diarrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gornoslaskie Centrum Mwdyczne

Gornoslaskie Centrum Mwdyczne

Ul. Ziolowa 45/47, Katowice, 40-635, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    Poland

  • Study on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    • Acetylsalicylic Acid
    Poland

  • Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Macitentan
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Study on Pirfenidone Inhalation Solution for Patients with Progressive Fibrosing Interstitial Lung Diseases, Including Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Pirfenidone
    Czechia The Netherlands Poland

  • Study on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma

    Not recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Poland Romania

  • Study of AB-1002 gene therapy given through coronary arteries in adults with severe (NYHA Class III) heart failure caused by non-ischemic cardiomyopathy

    Not recruiting

    2 1
    Investigated Drugs:
    • Ab-1002
    Austria Belgium Bulgaria Germany Hungary The Netherlands +3

  • Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

    Not recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Bulgaria Poland Romania

  • Study of prednisone and azathioprine treatment in patients with virus-negative myocarditis or inflammatory heart muscle disease with reduced heart pump function

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Azathioprine
    • Prednisone
    Poland

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +14
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!